These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3962800)

  • 41. Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome.
    Schaefer W
    Int J Urol; 2007 Jul; 14(7):670; author reply 670-1. PubMed ID: 17645621
    [No Abstract]   [Full Text] [Related]  

  • 42. Urge incontinence in elderly people: factors predicting the severity of urine loss before and after pharmacological treatment.
    Griffiths DJ; McCracken PN; Harrison GM; Moore KN
    Neurourol Urodyn; 1996; 15(1):53-7. PubMed ID: 8696356
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessing urinary incontinence in women.
    Harris A
    Nurs Times; 2007 Jun 26-Jul 2; 103(26):50-3. PubMed ID: 17629134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oxybutynin chloride combined with intermittent clean catheterization in the treatment of myelomeningocele patients.
    Mulcahy JJ; James HE; McRoberts JW
    J Urol; 1977 Jul; 118(1 Pt 1):95-6. PubMed ID: 327100
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of transdermal oxybutynin in patients with urge and mixed urinary incontinence.
    Dmochowski RR; Davila GW; Zinner NR; Gittelman MC; Saltzstein DR; Lyttle S; Sanders SW;
    J Urol; 2002 Aug; 168(2):580-6. PubMed ID: 12131314
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment of unstable bladder with oxybutynin hydrochloride. Our clinical experience in 80 cases].
    Alladio F; Arena G; Ferrando U; Pigato M; Sesia G
    Minerva Urol Nefrol; 1987; 39(4):359-62. PubMed ID: 3451374
    [No Abstract]   [Full Text] [Related]  

  • 47. S-oxybutynin.
    Drugs R D; 2002; 3(2):84-5. PubMed ID: 12001823
    [No Abstract]   [Full Text] [Related]  

  • 48. [Use of oxybutynin hydrochloride in the treatment of primary dysmenorrhea].
    Piato S; Delascio D
    Matern Infanc (Sao Paulo); 1968; 27(2):95-101. PubMed ID: 5746834
    [No Abstract]   [Full Text] [Related]  

  • 49. Mechanical misadministration of an oral hypoglycemic agent.
    Schlozman SC; Hennessey JV
    Diabetes Care; 1997 Nov; 20(11):1796-7. PubMed ID: 9353626
    [No Abstract]   [Full Text] [Related]  

  • 50. The use of oxybutynin in urological practice.
    Kirkali Z; Whitaker RH
    Int Urol Nephrol; 1987; 19(4):385-91. PubMed ID: 3429165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Urodynamic studies of female urinary incontinence. Personal experience].
    Carone R; Frea B; Tizzani A; Arena G; Ferrando U
    Minerva Urol; 1981; 33(1):41-2. PubMed ID: 7242508
    [No Abstract]   [Full Text] [Related]  

  • 52. Oxybutynin and intranasal desmopressin for clozapine-induced urinary incontinence.
    Lurie SN; Hosmer C
    J Clin Psychiatry; 1997 Sep; 58(9):404. PubMed ID: 9378693
    [No Abstract]   [Full Text] [Related]  

  • 53. Efficacy and safety of oxybutynin transdermal system in spinal cord injury patients with neurogenic detrusor overactivity and incontinence: an open-label, dose-titration study.
    Kennelly MJ; Lemack GE; Foote JE; Trop CS
    Urology; 2009 Oct; 74(4):741-5. PubMed ID: 19628264
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Female urinary incontinence and sex disorders: data from a urodynamic and psychoanalytic evaluation].
    Frigerio L; Maggioni C; Ferrari A
    Ann Ostet Ginecol Med Perinat; 1983; 104(2):100-3. PubMed ID: 6683951
    [No Abstract]   [Full Text] [Related]  

  • 55. [Neuro-urological findings in Williams syndrome: report of a case].
    Tobias-Machado M; Marinelli CM; Sakuramoto PK; Spinola RT; Borrelli Júnior M; Freire Gde C; Borrelli M
    Arq Neuropsiquiatr; 1998 Sep; 56(3B):683-7. PubMed ID: 9850771
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Images in neuroscience: urge incontinence and an abnormal patch of skin.
    Nguyen TT; Maartens NF
    J Clin Neurosci; 2005 Apr; 12(3):271-2, 295. PubMed ID: 15851080
    [No Abstract]   [Full Text] [Related]  

  • 57. Oxybutynin: a new drug with analgesic and anticholinergic properties.
    Diokno AC; Lapides J
    J Urol; 1972 Aug; 108(2):307-9. PubMed ID: 5047425
    [No Abstract]   [Full Text] [Related]  

  • 58. Using flavoxate as primary medication for patients suffering from urge symptomatology.
    Fehrmann-Zumpe P; Karbe K; Blessman G
    Int Urogynecol J Pelvic Floor Dysfunct; 1999; 10(2):91-5. PubMed ID: 10384969
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Successful Treatment of Neoplastic Fever with Oxybutynin.
    Yarchoan M; Tucker W; Smith TJ
    J Palliat Med; 2019 Dec; 22(12):1491. PubMed ID: 31794374
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical aspects of tethered cord syndrome in adults. Presentation of 2 cases].
    Salvati M; Ramundo Orlando E; Caruso R; Martini S; Artizzu S; Cosentino F; Cosentino F
    G Chir; 1990; 11(1-2):44-6. PubMed ID: 2078216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.